Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. 2019

Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
Department of Urology, Mayo Clinic, Rochester, MN, USA; Southern Alberta Institute of Urology, Calgary, Alberta, Canada.

Partial nephrectomy (PN) is generally favored for cT1 tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit. To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30d following PN and RN, separately. In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15ml/min/1.73m2. RN and PN. Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal RGLMM2, which ranges from 0 to 1, with higher values indicating increased predictive ability. The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66ml/min/1.73m2 (standard deviation [SD]=18) and 72ml/min/1.73m2 (SD=20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal RGLMM2=0.41). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal RGLMM2). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts. We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making. We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D005260 Female Females

Related Publications

Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
October 2012, Der Urologe. Ausg. A,
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
February 2023, Urologic oncology,
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
January 2012, Urologia internationalis,
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
January 2008, Urologiia (Moscow, Russia : 1999),
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
January 2013, Korean journal of urology,
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
October 2010, Canadian Urological Association journal = Journal de l'Association des urologues du Canada,
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
December 2016, Urologic oncology,
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
June 2015, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
April 2022, World journal of urology,
Bimal Bhindi, and Christine M Lohse, and Phillip J Schulte, and Ross J Mason, and John C Cheville, and Stephen A Boorjian, and Bradley C Leibovich, and R Houston Thompson
June 2012, International urology and nephrology,
Copied contents to your clipboard!